Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) | PAR-24-321 | NIA | The objective of the NIA Academic Leadership Career Award (K07) is to provide support for established investigators who have the expertise and leadership skills to enhance aging and/or Alzheimer… More | ||
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) | PAR-23-250 | NIAAA | The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus… More | ||
| Notice of Special Interest (NOSI): Competitive Revision Supplements to Existing T32 Programs to Include Institutional Research Training in Data Science for Infectious and Immune Mediated Diseases | NOT-AI-24-012 | NIAID | This Notice of Special Interest (NOSI) solicits competitive revision applications to support the expansion of existing National Institute of Allergy and Infectious Diseases (NIAID) T32 programs. This… More | ||
| Centers for Accelerating Phage (Bacteriophage) Therapy to Combat ESKAPE Pathogens (CAPT-CEP) (P01 Clinical Trial Not Allowed) | RFA-AI-24-069 | NIAID | The purpose of this notice of funding opportunity (NOFO) is to solicit applications to establish Centers for Accelerating Phage Therapy to Combat ESKAPE Pathogens (CAPT-CEP). These Centers will focus… More | ||
| U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional) | RFA-AI-24-023 | NIAID | The purpose of this Notice of Funding Opportunity (NOFO) is to support research projects under Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research. Research areas… More | ||
| Combating Antibiotic-Resistant Bacteria Interdisciplinary Research Units (CARBIRUs) (P01 Clinical Trial Not Allowed) | RFA-AI-24-074 | NIAID | The purpose of this notice of funding opportunity (NOFO) is to support multidisciplinary research programs focused on discovery to early development research to inform new approaches to prevent,… More | ||
| NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) | PAR-23-109 | NIAID | The purpose of the MSPP is to develop a diverse pool of combined-degree students (e.g., MD/PhD, DDS/PhD, DVM/PhD) who have conducted their PhD dissertation research at research laboratories in the… More | ||
| Notice of Special Interest (NOSI): Systems Modeling of Infection and Immunity Across Biological Scales | NOT-AI-24-060 | NIAID | The purpose of this Notice of Special Interest (NOSI) is to announce that the National Institute of Allergy and Infectious Diseases (NIAID) is encouraging applications to advance research activities… More | ||
| Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) | RFA-EB-21-001 | NIBIB | The purpose of this funding opportunity is to reduce health disparities through the development and translation of appropriate medical technologies. The NIH defines health disparities as differences… More | ||
| Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) | PAR-24-022 | NIBIB | This Trailblazer Award is an opportunity for NIH-defined New and Early Stage Investigators (https://grants.nih.gov/policy/early-investigators/index.htm) to pursue research programs that integrate… More |